A Systematic Review and Meta-Analysis of Randomized Trials: Terlipressin Related Survival Benefit and Adverse Events in Treating Hepatorenal Syndrome

被引：0
|
作者：
Moole, Harsha
Uppu, Achuta
Boddireddy, Raghuveer R.
Moole, Vishnu
Dharmapuri, Sowmya
Yerasi, Charan
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(16)31180-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1590
引用
收藏
页码：S336 / S336
页数：1
相关论文
共 50 条
  • [1] Survival Benefit and Morbidity With Terlipressin Plus Albumin in Treating Hepatorenal Syndrome: A Systematic Review and Meta-Analysis
    Moole, Harsha
    Ahmed, Zohair
    Duvvuri, Abhiram
    Moole, Vishnu
    Koppe, Sean
    [J]. HEPATOLOGY, 2016, 64 : 1038A - 1038A
  • [2] Terlipressin for hepatorenal syndrome: A meta-analysis of randomized trials
    Fabrizi, Fabrizio
    Dixit, Vivek
    Messa, Piergiorgio
    Martin, Paul
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2009, 32 (03): : 133 - 140
  • [3] Efficacy of Terlipressin and Albumin in Treating Hepatorenal Syndrome: A Meta-Analysis and Systematic Review
    Moole, Harsha
    Moole, Vishnu
    Ahmed, Zohair
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S841 - S841
  • [4] Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis
    Mirela Dobre
    Sevag Demirjian
    Ashwini R. Sehgal
    Sankar D. Navaneethan
    [J]. International Urology and Nephrology, 2011, 43 : 175 - 184
  • [5] Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis
    Dobre, Mirela
    Demirjian, Sevag
    Sehgal, Ashwini R.
    Navaneethan, Sankar D.
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2011, 43 (01) : 175 - 184
  • [6] Terlipressin in the treatment of hepatorenal syndrome A systematic review and meta-analysis
    Wang, Haiqing
    Liu, Aixiang
    Bo, Wentao
    Feng, Xielin
    Hu, Yong
    [J]. MEDICINE, 2018, 97 (16)
  • [7] Terlipressin effect on hepatorenal syndrome: Updated meta-analysis of randomized controlled trials
    Mohamed, Mohamed M. G.
    Rauf, Abdul
    Adam, Abubakr
    Kheiri, Babikir
    Lacasse, Alexandre
    El-Halawany, Hani
    [J]. JGH OPEN, 2021, 5 (08): : 896 - 901
  • [8] VASOACTIVE DRUGS FOR HEPATORENAL SYNDROME: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS
    Gluud, Lise L.
    Christensen, Kurt
    Christensen, Erik
    Krag, Aleksander
    [J]. HEPATOLOGY, 2009, 50 (04) : 469A - 469A
  • [9] Terlipressin versus Norepinephrine in the Treatment of Hepatorenal Syndrome: A Systematic Review and Meta-Analysis
    Nassar Junior, Antonio Paulo
    Farias, Alberto Queiroz
    Carneiro d' Albuquerque, Luiz Augusto
    Carrilho, Flair Jose
    Sa Malbouisson, Luiz Marcelo
    [J]. PLOS ONE, 2014, 9 (09):
  • [10] Terlipressin therapy for reversal of type 1 hepatorenal syndrome: A meta-analysis of randomized controlled trials
    Sagi, Sashidhar V.
    Mittal, Sahil
    Kasturi, Krishna S.
    Sood, Gagan K.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (05) : 880 - 885
12345